News

Inflazome, a startup company developing treatments for inflammatory diseases based on a research partnership between The University of Queensland and Trinity College Dublin (TCD) has been acquired in a landmark deal by Roche.

Molecules from the venom of one of the world’s largest spiders could help tailor pain blockers for people with irritable bowel syndrome (IBS).

IMB researchers have discovered the neurotoxin in the giant stinging tree targets the same receptors as spider and cone snail toxins.

A healthy gut might be impacting the longevity of people living with Motor Neurone Disease (MND), but not in the way you may first suspect.

Some new studies have found people who were never symptomatic, exposed to, or tested positive for COVID-19 that have immune cells that can recognise COVID-19.

IMB researchers are continuing their search for new, eco-friendly pesticides with the support of the Australian Research Council.

An affordable diabetes drug, metformin, could save generations of Australian families who live with polycystic kidney disease from kidney failure.

Sex on the reef became a little weirder with new research suggesting algae that live in partnership with coral use a distinct way of exchanging DNA during sex.

An Australian scientist born in the Netherlands has been given a lifetime honour by a European organisation in recognition of his outstanding achievements in life sciences.

Professor Jian Yang is taking his considerable talents back to his homeland of China, leaving behind a legacy of world-class research.

IMB researchers have investigated a peptide from the marine sandworm, which has the power to kill superbugs.

A new antibiotic, Octapeptin-X that targets the most dangerous drug-resistant bacteria has been given a funding boost by CARB-X.

Instead of protecting us from the virus that causes COVID-19, the body's natural defence mechanisms can overreact and inflict damage. Understanding why could make the infection far less dangerous.

Sheep poo could hold the key to developing the next generation of antiparasitic treatments that could protect Australian livestock and save the industry millions of dollars a year.

A mission to reprogram innate immunity to combat inflammatory and infectious diseases has been supported by the National Health and Medical Research Council.

Nearly two million antibody tests imported into Australia are not much better than flipping a coin.

Bacteria and viruses are all around us - some beneficial and some fatal.

Molecules in tarantula venom could be used as an alternative to opioid pain killers for people seeking chronic pain relief.

UQ researchers investigating genes linked with vitamin D have discovered genetic variations in the skin that can create a natural sunscreen.

With much of society now effectively in lockdown, how will we know when it’s safe to resume something like normality?